Take the first step toward a more rewarding career
Phase 2 and Phase 3 trial data Major clinical trials: Phase 2 (24-week trial, 2008): 203 obese participants Three dose groups: 0.25mg, 0.5mg, 1.0mg daily Placebo-controlled, randomized Primary outcome: Weight loss percentage Phase 2 results: Key findings: Dose-dependent weight loss 1mg dose: Average 23 lbs lost (starting weight ~220 lbs) Best responders: 15-20% weight loss Comparable to semaglutide 2.4mg But higher dropout due to side effects Phase 3 trials (planned but never completed): Intended for FDA approval Halted due to cardiovascular concerns Increased heart rate 5-10 bpm average Blood pressure elevation 2-5 mmHg Risk-benefit ratio questioned Development suspended 2010 Long-term data (limited): 1-year extension studies showed sustained loss Weight plateau at 6-9 months Some regain if discontinued No controlled trials beyond 1 year Safety concerns prevented longer studies Compare to semaglutide trials and tirzepatide results
N-Acetyl-Carnitine N-Acetyl-Carnitine is an acetylated form of the amino acid-like molecule L-carnitine
Neuronally derived extracellular vesicle -synuclein as a serum biomarker for individuals at risk of developing Parkinson disease
Some of the amino acids, e.g., glycinebetaine (betaine), proline (Pro), histidine (His), cysteine (Cys), arginine (Arg), glutamate (Glu), nicotianamine (NA), and the polyamines (spermidine, Spd
If you want to have a little volume to your hair add some texture powder to the top of your hair, then gently pinch and massage your roots for texture and volume
.webp)